158 related articles for article (PubMed ID: 17134887)
1. Interaction of macrocyclic lactones with P-glycoprotein: structure-affinity relationship.
Lespine A; Martin S; Dupuy J; Roulet A; Pineau T; Orlowski S; Alvinerie M
Eur J Pharm Sci; 2007 Jan; 30(1):84-94. PubMed ID: 17134887
[TBL] [Abstract][Full Text] [Related]
2. Selamectin is a potent substrate and inhibitor of human and canine P-glycoprotein.
Griffin J; Fletcher N; Clemence R; Blanchflower S; Brayden DJ
J Vet Pharmacol Ther; 2005 Jun; 28(3):257-65. PubMed ID: 15953199
[TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein interfering agents potentiate ivermectin susceptibility in ivermectin sensitive and resistant isolates of Teladorsagia circumcincta and Haemonchus contortus.
Bartley DJ; McAllister H; Bartley Y; Dupuy J; Ménez C; Alvinerie M; Jackson F; Lespine A
Parasitology; 2009 Aug; 136(9):1081-8. PubMed ID: 19549355
[TBL] [Abstract][Full Text] [Related]
4. Interaction of ivermectin with multidrug resistance proteins (MRP1, 2 and 3).
Lespine A; Dupuy J; Orlowski S; Nagy T; Glavinas H; Krajcsi P; Alvinerie M
Chem Biol Interact; 2006 Feb; 159(3):169-79. PubMed ID: 16384552
[TBL] [Abstract][Full Text] [Related]
5. Role of P-glycoprotein in the disposition of macrocyclic lactones: A comparison between ivermectin, eprinomectin, and moxidectin in mice.
Kiki-Mvouaka S; Ménez C; Borin C; Lyazrhi F; Foucaud-Vignault M; Dupuy J; Collet X; Alvinerie M; Lespine A
Drug Metab Dispos; 2010 Apr; 38(4):573-80. PubMed ID: 20089736
[TBL] [Abstract][Full Text] [Related]
6. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
[TBL] [Abstract][Full Text] [Related]
7. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
[TBL] [Abstract][Full Text] [Related]
8. Interaction of tomato lectin with ABC transporter in cancer cells: glycosylation confers functional conformation of P-gp.
Molnár J; Kars MD; Gündüz U; Engi H; Schumacher U; Van Damme EJ; Peumans WJ; Makovitzky J; Gyémánt N; Molnár P
Acta Histochem; 2009; 111(4):329-33. PubMed ID: 19124148
[TBL] [Abstract][Full Text] [Related]
9. Fumagillin, a new P-glycoprotein-interfering agent able to modulate moxidectin efflux in rat hepatocytes.
Dupuy J; Lespine A; Sutra JF; Alvinerie M
J Vet Pharmacol Ther; 2006 Dec; 29(6):489-94. PubMed ID: 17083452
[TBL] [Abstract][Full Text] [Related]
10. A high-throughput screening microplate test for the interaction of drugs with P-glycoprotein.
Garrigues A; Nugier J; Orlowski S; Ezan E
Anal Biochem; 2002 Jun; 305(1):106-14. PubMed ID: 12018951
[TBL] [Abstract][Full Text] [Related]
11. Acridones circumvent P-glycoprotein-associated multidrug resistance (MDR) in cancer cells.
Gopinath VS; Thimmaiah P; Thimmaiah KN
Bioorg Med Chem; 2008 Jan; 16(1):474-87. PubMed ID: 17933543
[TBL] [Abstract][Full Text] [Related]
12. Effect of Stemona curtisii root extract on P-glycoprotein and MRP-1 function in multidrug-resistant cancer cells.
Limtrakul P; Siwanon S; Yodkeeree S; Duangrat C
Phytomedicine; 2007 Jun; 14(6):381-9. PubMed ID: 17467965
[TBL] [Abstract][Full Text] [Related]
13. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Haemonchus contortus P-glycoprotein-16 and its interaction with the macrocyclic lactone anthelmintics.
Godoy P; Che H; Beech RN; Prichard RK
Mol Biochem Parasitol; 2015 Nov; 204(1):11-5. PubMed ID: 26657092
[TBL] [Abstract][Full Text] [Related]
15. Macrocyclic lactones differ in interaction with recombinant P-glycoprotein 9 of the parasitic nematode Cylicocylus elongatus and ketoconazole in a yeast growth assay.
Kaschny M; Demeler J; Janssen IJ; Kuzmina TA; Besognet B; Kanellos T; Kerboeuf D; von Samson-Himmelstjerna G; Krücken J
PLoS Pathog; 2015 Apr; 11(4):e1004781. PubMed ID: 25849454
[TBL] [Abstract][Full Text] [Related]
16. Modulation of P-glycoprotein-mediated resistance by kaempferol derivatives isolated from Zingiber zerumbet.
Chung SY; Jang DS; Han AR; Jang JO; Kwon Y; Seo EK; Lee HJ
Phytother Res; 2007 Jun; 21(6):565-9. PubMed ID: 17335117
[TBL] [Abstract][Full Text] [Related]
17. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
[TBL] [Abstract][Full Text] [Related]
18. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
Wang TX; Yang XH
Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
[TBL] [Abstract][Full Text] [Related]
19. Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives.
Colabufo NA; Berardi F; Cantore M; Perrone MG; Contino M; Inglese C; Niso M; Perrone R; Azzariti A; Simone GM; Porcelli L; Paradiso A
Bioorg Med Chem; 2008 Jan; 16(1):362-73. PubMed ID: 17936633
[TBL] [Abstract][Full Text] [Related]
20. Marked impact of P-glycoprotein on the absorption of TAK-427 in rats.
Takeuchi T; Nonaka M; Yoshitomi S; Higuchi T; Ebihara T; Maeshiba Y; Kawase M; Asahi S
Biopharm Drug Dispos; 2008 Sep; 29(6):311-23. PubMed ID: 18651556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
